Search Results

Displaying Results 1201-1225 of 20448 "'R'"

Aug 24, 2026, 08:39 ET Leqembi Iqlik® for initiation treatment launched in the US

https://news.cision.com/bioarctic/r/leqembi-iqlik--for-initiation-treatment-launched-in-the-us,c4387047The following files are available for download:

More news about: BioArctic


Aug 24, 2026, 08:35 ET WuXi XDC Delivers Strong First Half 2026 Performance, with Improving Margins and Profitability Further Strengthening Global ADC/XDC CRDMO Leadership

the Group explored over 22,000 ADC/XDC molecules cumulatively as at the end of the Reporting Period.Development of Fully Integrated R&D Technology Platform During 2026 1HThe Group provides customers with innovative conjugation and payload-linker technologies to accelerate

More news about: WuXi XDC


Aug 24, 2026, 08:33 ET EverestLabs Launches First-Ever Agentic AI Platform for Materials Processing, Recovery and Recycling Facilities

not available."The next great frontier for AI is in the scrap yards, recycling and waste streams that underpin our industrial economy," said R. Paul Singh, CEO of EverestLabs. "By deploying Physical AI to recover the 93% of raw materials we currently never reuse, we're not just boosting recycling—we're

More news about: EverestLabs


Aug 24, 2026, 08:30 ET FibroBiologics Appoints Leigh Steinberg to Board of Directors

its business; (b) expectations regarding the initiation, progress and expected results of FibroBiologics' R&D efforts and preclinical studies; (c) the unpredictable relationship between R&D and preclinical results and clinical study results; (d) the ability of FibroBiologics to successfully prosecute

More news about: FibroBiologics, Inc.


Aug 24, 2026, 08:10 ET Leading Parkinson's Organizations Outline Priorities for the National Plan Ahead of Advisory Council Meeting

community that helps everyone impacted by PD live life to the fullest. Through a nationwide grassroots network of Chapters and Information & Referral (I&R) Centers, APDA works tirelessly to raise public awareness of this chronic neurologic movement disorder and deliver outstanding patient services, resources,

More news about: Parkinson's Foundation


Aug 24, 2026, 08:00 ET Quantum-Systems Inc. Expands U.S. Footprint with New Huntsville R&D Office

next-generation unmanned systems grounded in operational requirements.The new Huntsville office supports this model by placing engineering and R&D resources closer to defense customers and partners. This proximity enables direct collaboration, integration of operational feedback, and accelerated

More news about: Quantum-Systems Inc.


Aug 24, 2026, 08:00 ET Avulux Granted FDA De Novo Authorization, Creating the First Lens Classification for Migraine-Associated Light Sensitivity

adolescents and young adults: a 30-year analysis (1990–2021). Front. Neurol. 16:1652468. doi: 10.3389/fneur.2025.16524687 Noseda R, Kainz V, Jakubowski M, et al. A neural mechanism for exacerbation of headache by light. Nat Neurosci. 2010;13(2):239-245. doi:10.1038/nn.24758

More news about: Avulux


Aug 24, 2026, 08:00 ET LEQEMBI IQLIK®(lecanemab-irmb) Autoinjector for Initiation of Therapy Now Available in the U.S. for Early Alzheimer's Disease

Concept), we aim to effectively achieve social good in the form of relieving anxiety over health and reducing health disparities. With a global network of R&D facilities, manufacturing sites and marketing subsidiaries, we strive to create and deliver innovative products to target diseases with high unmet

More news about: Eisai Inc.


Aug 24, 2026, 07:00 ET Pulsenmore Ltd. To Announce Financial Results and Business Highlights and Hold Conference Call for the First Half of 2026

Webcast: https://teams.microsoft.com/meet/35050418577919?p=r5gfAIMDL65KJ8zKj3 Replay: A replay of the webcast will be available following the call on the Company's Investor

More news about: Pulsenmore Ltd.


Aug 24, 2026, 07:00 ET Vanda Pharmaceuticals Granted Orphan Designation for Imsidolimab for the Treatment of Generalized Pustular Psoriasis by the European Commission

10, 2026. [Online]. Available: https://www.nanbyou.or.jp/entry/168H. Fujita, R. Iwasaki, S. Tsuboi, Y. Murashiuma, and M. Akiyama, "Regional differences in the prevalence of generalized pustular psoriasis in Japan," J. Dermatol.,

More news about: Vanda Pharmaceuticals Inc.


Aug 24, 2026, 07:00 ET Scinai Reports First Half 2026 Corporate Highlights and Results with Spotlight on Growing CDMO Momentum

progress this significant U.S. opportunity and continue advancing our therapeutic programs with disciplined capital allocation."R&D UpdateScinai continues to pursue a capital-efficient development strategy focused on PC111 and its NanoAbs platform.

More news about: Scinai Immunotherapeutics Ltd.


Aug 24, 2026, 07:00 ET Roche receives FDA clearance for Elecsys® pTau217, advancing Alzheimer's disease assessment across primary and specialty care

amyloid pathology in patients with cognitive impairment, these approaches may be costly, invasive and not readily accessible for many patients," said Jared R. Brosch, M.D., Neurologist, Indiana University Health. "Advances in blood-based biomarkers have the potential to transform the diagnostic pathway by expanding

More news about: Roche Diagnostics


Aug 24, 2026, 06:30 ET XPENG Reports Second Quarter 2026 Unaudited Financial Results

commercialization of physical AI technologies to accelerate over the coming year, generating meaningful gross profit growth to support our continued R&D investment in physical AI."Recent DevelopmentsDeliveries in July 2026Total

More news about: XPeng Inc.


Aug 24, 2026, 06:08 ET XPENG robotics business raises over US$900 million at a post-money valuation of over US$6.3 billion, accelerating physical AI deployment

Tencent and Alibaba as strategic investors.The funding will accelerate XPENG humanoid robotics mass production and Physical AI model R&D iterations, driving advanced general-purpose humanoid robot toward a new stage of global commercialization.GUANGZHOU,

More news about: XPENG


Aug 24, 2026, 06:02 ET Anderson & Vreeland Launches Innovative AVantage Liquid Resin Laboratory

research team is foundational tools to carry out their work- such as advanced instrumentation and laboratory environments," states Ryan Vest, Director of R&D and AVantage Technology. "The AVantage Technical Support and Development Laboratory is a key investment that will enable the AVantage team to further

More news about: Anderson & Vreeland Inc.


Aug 24, 2026, 05:40 ET BlueNord: Minutes from Extraordinary General Meeting - Merger Plan with Vår Energi Approved

https://news.cision.com/bluenord-asa/r/bluenord--minutes-from-extraordinary-general-meeting---merger-plan-with-var-energi-approved,c4386904The following files are available for download:

More news about: BlueNord ASA


Aug 24, 2026, 05:35 ET European Commission grants orphan designation for Lundbeck's investigational anti-ACTH monoclonal antibody asedebart for Cushing's syndrome of endogenous origin

important recognition of both the unmet need in Cushing's and the scientific rationale behind asedebart," said Johan Luthman, Executive Vice President, R&D, Lundbeck. "The asedebart program is a good representation of the type of strong targeted mechanism programs we like to advance in Lundbeck. The orphan

More news about: H. Lundbeck A/S


Aug 24, 2026, 05:33 ET European Commission grants orphan designation for Lundbeck's investigational anti-ACTH monoclonal antibody asedebart for Cushing's syndrome of endogenous origin

important recognition of both the unmet need in Cushing's and the scientific rationale behind asedebart," said Johan Luthman, Executive Vice President, R&D, Lundbeck. "The asedebart program is a good representation of the type of strong targeted mechanism programs we like to advance in Lundbeck. The orphan

More news about: H. Lundbeck A/S


Aug 24, 2026, 05:27 ET American Parkinson Disease Association Launches Spanish-Language Microsite, Expanding Support for Underserved Parkinson's Community

community that helps everyone impacted by PD live life to the fullest. Through a nationwide grassroots network of Chapters and Information & Referral (I&R) Centers, APDA works tirelessly to raise public awareness of this chronic neurologic movement disorder and deliver outstanding patient services, resources,

More news about: American Parkinson Disease Association, Inc.


Aug 24, 2026, 04:30 ET Camel Group's 12V Sodium-Ion Battery Selected for European OEM Pre-Development Project

follows the adoption of Camel Group's 12V lithium-ion batteries by major European automakers and represents another step in the company's overseas R&D collaboration in next-generation low-voltage battery technology.Sodium-ion batteries are attracting increasing attention in automotive applications

More news about: Camel Group Co.,Ltd.


Aug 24, 2026, 03:26 ET MacGregor extends Horizon gangway to floating-to-floating personnel transfer

https://news.cision.com/macgregor/r/macgregor-extends-horizon-gangway-to-floating-to-floating-personnel-transfer,c4386424The following files are available for download:

More news about: MacGregor


Aug 24, 2026, 03:20 ET MacGregor advances direct ship-to-well LCO₂ transfer, built on 50 years of proven bow-loading technology

https://news.cision.com/macgregor/r/macgregor-advances-direct-ship-to-well-lco--transfer--built-on-50-years-of-proven-bow-loading-techno,c4386403The following files are available for download:

More news about: MacGregor


Aug 24, 2026, 03:15 ET Scania to showcase its broad marine offering at SMM 2026

https://news.cision.com/scania/r/scania-to-showcase-its-broad-marine-offering-at-smm-2026,c4383473The following files are available for download:

More news about: Scania


Aug 24, 2026, 03:06 ET Share buybacks in Ericsson during the period August 17 - August 21, 2026

https://news.cision.com/ericsson/r/share-buybacks-in-ericsson-during-the-period-august-17---august-21--2026,c4386704The following files are available for download:

More news about: Ericsson


Aug 24, 2026, 03:02 ET Share buybacks in Ericsson during the period August 17 - August 21, 2026

https://news.cision.com/ericsson/r/share-buybacks-in-ericsson-during-the-period-august-17---august-21--2026,c4386704The following files are available for download:

More news about: Ericsson


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.